{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:38:09Z","timestamp":1771472289780,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As a rare neurodegenerative disease, sporadic Creutzfeldt-Jakob disease (sCJD) is poorly understood in the elderly populace. This study aims to enunciate the multidimensional features of sCJD in this group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A case of probable sCJD was reported in a 90-year-old Chinese man with initial dizziness. Then, available English literature of the elderly sCJD cases (aged 80 years and over) was reviewed and analyzed. Patients (15 cases) were subdivided and compared geographically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the elderly sCJD cohort, the onset age was 84.9 \u00b1 4.5 years and the median disease duration was 6.8 months, with respiratory infection\/failure as the commonest death cause. Various clinical symptoms were identified, with cognitive disorder (86.7%) as the commonest typical symptom and speech impairment (66.7%) as the most atypical one. Restricted hyperintensities were reported in 60.0% cases on DWI, periodic sharp wave complexes in 73.3% cases on electroencephalogram, and cerebral hypoperfusion\/hypometabolism in 26.7% cases on molecular imaging. The sensitive cerebrospinal fluid biomarkers were total tau (83.3%), 14-3-3 protein (75.0%), and PrP RT-QuIC (75.0%). Neuropathological profiles in the cerebral cortex revealed vacuolar spongiosis, neuronal loss, gliosis, and aging-related markers, with synaptic deposit as the commonest PrP pattern (60.0%). The polymorphic <jats:italic>PRNP<\/jats:italic> analysis at codon 129 was M\/M (90.9%), with MM1 and MM2C as the primary molecular phenotypes. Latency to first clinic visit, hyperintense signals on DWI, and disease duration were significantly different between the patient subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The characteristics of sCJD are multidimensional in the elderly, deepening our understanding of the disease and facilitating an earlier recognition and better care for this group.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2024.1379011","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:54:00Z","timestamp":1712638440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Multidimensional features of sporadic Creutzfeldt-Jakob disease in the elderly: a case report and systematic review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiangfeng","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senwei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1468-1331.2002.00456.x","article-title":"A French cluster of Creutzfeldt-Jakob disease: A molecular analysis.","volume":"9","author":"Beaudry","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging.","volume":"77","author":"Bizzi","year":"2020","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ana.20568","article-title":"Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.","volume":"58","author":"Boesenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/jnnp.2008.166447","article-title":"The oldest old Creutzfeldt-Jakob disease case.","volume":"80","author":"Buganza","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/pgmj.73.863.557","article-title":"Creutzfeldt-Jakob disease in the elderly.","volume":"73","author":"de Silva","year":"1997","journal-title":"Postgrad. Med. J."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.50.2300101","article-title":"Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: A slow waning of epidemics and an increase in observed sporadic forms.","volume":"28","author":"Denouel","year":"2023","journal-title":"Euro Surveill."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/ene.14624","article-title":"Sporadic Creutzfeldt-Jakob disease with tau pathology mimicking new-onset refractory non-convulsive status epilepticus: Case report and review of the literature.","volume":"28","author":"Gonzalez-Martinez","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/19336896.2019.1631680","article-title":"Clinicopathological findings of an mm2-cortical-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration.","volume":"13","author":"Hayashi","year":"2019","journal-title":"Prion"},{"key":"B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/psyg.12272","article-title":"A sporadic case of Creutzfeldt-Jakob disease showing unilateral hemispheric involvement on magnetic resonance imaging.","volume":"17","author":"Hirao","year":"2017","journal-title":"Psychogeriatrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/neup.12557","article-title":"Autopsied case of sporadic Creutzfeldt-Jakob disease classified as mm1+2c-type.","volume":"39","author":"Iwasaki","year":"2019","journal-title":"Neuropathology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1440-1827.1999.00883.x","article-title":"Argyrophilic grains in late-onset Creutzfeldt-Jakob diseased-brain.","volume":"49","author":"Kawashima","year":"1999","journal-title":"Pathol. Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1007\/s12035-021-02427-5","article-title":"The roles of peroxiredoxin 6 in brain diseases.","volume":"58","author":"Liao","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/19336896.2017.1314427","article-title":"Amyloid- and FDG-pet in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.","volume":"11","author":"Matias-Guiu","year":"2017","journal-title":"Prion"},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/19336896.2019.1706703","article-title":"An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative heidenhain-variant mm1-scjd.","volume":"14","author":"Obergassel","year":"2020","journal-title":"Prion"},{"key":"B17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00401-008-0394-y","article-title":"Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.","volume":"116","author":"Paquet","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann. Neurol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13214","article-title":"Enhanced Creutzfeldt-Jakob disease surveillance in the older population: Assessment of a protocol for screening brain tissue donations for prion disease.","volume":"34","author":"Peden","year":"2024","journal-title":"Brain Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/19336896.2017.1387348","article-title":"Fdg-pet in Creutzfeldt-Jakob disease: Analysis of clinical-pet correlation.","volume":"11","author":"Renard","year":"2017","journal-title":"Prion"},{"key":"B21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jamaneurol.2019.1071","article-title":"Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease.","volume":"76","author":"Staffaroni","year":"2019","journal-title":"JAMA Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ana.20261","article-title":"Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.","volume":"56","author":"Steinhoff","year":"2004","journal-title":"Ann. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00415-022-11467-3","article-title":"Sporadic Creutzfeldt-Jakob disease in the young (50 and below): 10-year review of United Kingdom surveillance.","volume":"270","author":"Tam","year":"2023","journal-title":"J. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/neup.12911","article-title":"An autopsy case of variably protease-sensitive prionopathy with met\/met homogeneity at codon 129.","volume":"43","author":"Uchino","year":"2023","journal-title":"Neuropathology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","article-title":"Creutzfeldt-Jakob disease: A systematic review of global incidence, prevalence, infectivity, and incubation.","volume":"20","author":"Uttley","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","article-title":"EEG in Creutzfeldt-Jakob disease.","volume":"117","author":"Wieser","year":"2006","journal-title":"Clin. Neurophysiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"}],"updated-by":[{"DOI":"10.3389\/fnagi.2025.1565464","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000}}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1379011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T13:14:37Z","timestamp":1738847677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1379011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":27,"alternative-id":["10.3389\/fnagi.2024.1379011"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1379011","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fnagi.2025.1565464","asserted-by":"object"}]},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"article-number":"1379011"}}